Why The Drive For Medical Transition Should Be Re-Psychopathologized (#42)
9 October 2025
Global
Fifteen years after WPATH declared trans identities 'natural and healthy' and stripped away psychiatric safeguards, Genspect has launched a formal campaign to reverse that decision. Mia Hughes and Stella O'Malley explain why the drive toward extreme medical body modification in young people must be recognised as pathological — and why the WHO's ICD-11 reclassification, adopted across European health systems, makes this debate urgently relevant for clinicians and policymakers on the continent.
In 2010 WPATH issued a statement declaring that gender variance was neither a disorder nor a pathology, a position that would ripple through diagnostic manuals, clinical guidelines and health ministries for the decade that followed. Mia Hughes and Stella O'Malley sit down together in this episode to reconstruct that history and to explain the reasoning behind Genspect's new counter-campaign: a formal call to re-psychopathologize the compulsive drive toward irreversible medical intervention in young people who are distressed about their bodies. The distinction the episode develops is careful and important. Exploring a trans identity, questioning one's sense of gender, living outside conventional norms — none of that is being labelled pathological. What warrants clinical concern, the hosts argue, is the obsessive, escalating pursuit of surgeries and hormones that permanently alter healthy tissue, particularly when that pursuit is displacing every other aspect of a young person's psychological and social development. It is the behaviour, not the identity, that calls for mental health support. For European audiences the institutional chronology matters enormously. The DSM-5 revision of 2013 replaced 'Gender Identity Disorder' with 'Gender Dysphoria', repositioning distress as the clinical problem rather than any underlying condition. Five years later the WHO's ICD-11 went further, moving gender incongruence out of the mental health chapter altogether and into a section on sexual health. European countries whose health systems are built around ICD coding — which is most of them — absorbed that shift into funding decisions, referral pathways and training curricula, often without public debate. Sweden, Finland and Denmark have since conducted systematic reviews and pulled back sharply on paediatric medical pathways, citing precisely the absence of the safeguards this episode describes. France has convened its own expert commission. In the Netherlands, where the original 'Dutch protocol' was developed and long held as the international gold standard, clinicians have grown visibly cautious about the populations now presenting to gender services. Yet the WHO and WPATH frameworks remain the formal reference points for the majority of EU member states, and for the European clinical bodies that set continuing professional development standards. The gap between emerging national evidence and supranational institutional doctrine is widening. Hughes and O'Malley also examine the concept of 'extreme overvalued belief', drawn from nineteenth-century psychiatry and more recently revived in forensic and clinical literature. Applying that framework to the drive for medical transition gives clinicians a language and a rationale for genuine therapeutic engagement rather than immediate affirmation — something a generation of gender-service staff across Europe have been told they must not do. The Genspect campaign is unlikely to move the WHO or WPATH quickly, but its significance for Europe lies elsewhere. It gives national health authorities, professional associations and individual clinicians a documented, argued basis for restoring the kind of thorough psychological assessment that countries like Sweden have already reinstated by other means. For a continent whose health systems were reshaped by a single WPATH statement in 2010, understanding how that statement came to be — and why its premises are now being formally challenged — is essential context.
